PMAC Welcomes Fred Hutchinson Cancer Center to Advance Global Precision Oncology

New York, NY — December 20, 2025 — PMAC (Precision Medicine Action for Cancer), a multi-insitutional academic consortium focused on accelerating the integration of precision medicine into oncology, is proud to announce that Fred Hutchinson Cancer Center (Fred Hutch) has officially joined as a participating institution.

The addition of Fred Hutch, a world-renowned pioneer in cancer research and treatment, marks a significant expansion of the Consortium’s clinical and genomic research capabilities. Based in Seattle, Fred Hutch is home to some of the world’s leading experts in cancer research and treatment.

As part of this new partnership, Marko Velimirovic will join the PMAC Steering Committee. In this role, Velimirovic will represent Fred Hutch in shaping PMAC's strategic initiatives, ensuring that collaborative research efforts are translated into scalable clinical solutions for patients worldwide.

"We are honored to welcome Fred Hutchinson Cancer Center to PMAC ," said Massimo Cristofanilli, PMAC President and CEO. "Their legacy of innovation and commitment to curing cancer aligns perfectly with our mission. Having Marko Velimirovic on our Steering Committee will provide the leadership and expertise necessary to drive the next generation of precision medicine breakthroughs."

PMAC continues to grow its global footprint, uniting the brightest minds in science and technology to ensure that every cancer patient receives a treatment plan tailored to their unique characteristics.

About PMAC

PMAC is a multi-institutional consortium dedicated to the advancement of precision medicine for cancer research and care. By bridging the gap between research evidence and clinical application, PMAC aims to accelerate the delivery of personalized therapies to patients globally.

About Fred Hutchinson Cancer Center

Fred Hutchinson Cancer Center is an independent, nonprofit organization and one of the nation’s top-ranked cancer centers. Fred Hutch is dedicated to the prevention, diagnosis, and treatment of cancer and related diseases.